GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intercept Pharmaceuticals Inc (FRA:I4P) » Definitions » Other Liabilities for Insurance Companies

Intercept Pharmaceuticals (FRA:I4P) Other Liabilities for Insurance Companies


View and export this data going back to 2012. Start your Free Trial

What is Intercept Pharmaceuticals Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Intercept Pharmaceuticals (FRA:I4P) Business Description

Industry
Traded in Other Exchanges
N/A
Address
305 Madison Avenue, Morristown, NJ, USA, 07960
Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.